Pharma Deals Review, Vol 2008, No 91 (2008)

Font Size:  Small  Medium  Large

MorphoSys AG

Business Review Editor

Abstract


MorphoSys is a biotechnology company that focuses on the development of fully human antibodies for therapeutic, research and diagnostics purposes. The company has a number of unique proprietary technologies most of which is HuCAL ® technology (Human Combinatorial Antibody Library). This technology is based on phage display and provides a seamless transition from a rapidly generated antibody fragment (Fab) with strong binding characteristics to a fully human antibody drug candidate in a rapid and automated production process.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.